Michel Zelaquett/LinkedIn
Apr 23, 2026, 07:33
Michel Zelaquett: Ultra-Minimally Invasive Treatment for Uterine Fibroids
Michel Zelaquett, Founder and Director at Centro de Mioma, shared a post on LinkedIn:
“Ultra-Minimally Invasive Treatment for Uterine Fibroids
No incisions. No scars. Minimal invasion, maximum precision.
Cutting-edge technology in service of uterine preservation and fertility — because every woman deserves access to treatments that respect her body and her future.
Proud to be part of a dedicated team pushing the boundaries of modern gynecology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 23, 2026, 07:29Asma Khalil: Highlights From Fetal Therapy 2026 in Warsaw
-
Apr 23, 2026, 07:24Christopher Robinson: Management of Immediate and Delayed PPT with Cesarean Delivery
-
Apr 23, 2026, 07:17The True Scale and Impact of Early Pregnancy Loss – Fertility Plus
-
Apr 23, 2026, 07:06Canada’s Blind Spot on Drug Safety in Pregnancy – SOGC
-
Apr 22, 2026, 13:13Kate Devine: SREI Advances REI Fellowship Training with Updated Learning Objectives
-
Apr 22, 2026, 13:07Vinesh Gadhia: India Takes the Stage at World AI in Fertility Conference 2026
-
Apr 22, 2026, 11:36Christopher Robinson: Vaginal Clamping of Uterine Arteries in Postpartum Hemorrhage
-
Apr 22, 2026, 11:25Naval Shah: IVF Lab Quality and Standardisation Take Centre Stage at ALPHA 2026
-
Apr 22, 2026, 11:09Khalil Faaed: Recent Updates in AI Are Advancing Embryology and ART